Helozine Oral Drops Orange contain Hydroxyzine at a concentration of 6 mg/ml, an antihistamine with anxiolytic, sedative, and antiemetic properties. It is primarily indicated for the symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested. Additionally, Helozine is effective in the management of pruritus due to allergic conditions such as chronic urticaria, atopic and contact dermatoses, and as a sedative agent prior to anesthesia. The oral drops formulation allows for flexible dosing, particularly suitable for pediatric and geriatric patients or those with swallowing difficulties. Hydroxyzine exerts its therapeutic effects by antagonizing H1 histamine receptors, thereby reducing histamine-mediated allergic symptoms and producing central nervous system depression that contributes to its anxiolytic and sedative actions. The orange-flavored formulation enhances palatability, improving patient compliance. Dosage should be individualized based on the severity of symptoms and patient response, with careful consideration of contraindications including hypersensitivity to Hydroxyzine or related compounds, and caution advised in patients with impaired hepatic or renal function. Common adverse effects include drowsiness, dry mouth, and headache. Helozine Oral Drops Orange should be used under medical supervision to ensure safety and efficacy.